Cargando…
Specific alterations in gut microbiota are associated with prognosis of Budd–Chiari syndrome
Gut microbiota is associated with liver diseases. However, gut microbial characteristics of Budd–Chiari syndrome (B-CS) have not been reported. Here, by MiSeq sequencing, gut microbial alterations were characterized among 37 health controls, 20 liver cirrhosis (LC) patients, 31 initial B-CS patients...
Autores principales: | Sun, Yu-Ling, Li, Wen-Qi, Ding, Peng-Xu, Wang, Zhi-Wei, Wei, Chang-Hua, Ma, Xiu-Xian, Zhang, Rui-Fang, Wu, Yan, Zhou, Lin, Liang, Ruo-Peng, Zhang, Yan-Peng, Zhao, Yi-Pu, Zhu, Rong-Tao, Li, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790465/ https://www.ncbi.nlm.nih.gov/pubmed/29423048 http://dx.doi.org/10.18632/oncotarget.23234 |
Ejemplares similares
-
Review of Budd-Chiari Syndrome
por: Zu, Maoheng, et al.
Publicado: (2020) -
Histopathology of Budd–Chiari Syndrome
por: Quaglia, Alberto
Publicado: (2023) -
Alterations in Faecal Metagenomics and Serum Metabolomics Indicate Management Strategies for Patients With Budd-Chiari Syndrome
por: Lu, Qinwei, et al.
Publicado: (2021) -
Identification of differentially expressed genes in Budd-Chiari syndrome by RNA-sequencing
por: Yang, Bin, et al.
Publicado: (2017) -
The application and efficacy of stent place for Budd-Chiari syndrome
por: Zu, Maoheng, et al.
Publicado: (2019)